Literature DB >> 9435570

Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.

K L Hartshorn1, M R White, V Shepherd, K Reid, J C Jensenius, E C Crouch.   

Abstract

The present study provides the first direct comparison of anti-influenza A virus (IAV) activities of the collectins surfactant protein (SP) A and SP-D, mannose-binding lectin (MBL), and conglutinin. SP-D, MBL, and conglutinin inhibited IAV hemagglutination activity with a greater potency than and by a distinct mechanism from SP-A. Although isolated trimeric SP-D carbohydrate recognition domains inhibited hemagglutination activity, preparations of SP-D also containing the collagen domain and NH2 terminus caused greater inhibition. In contrast to SP-A (or nonmultimerized SP-D), absence of the N-linked attachment did not effect interactions of multimerized SP-D with IAV. SP-D, SP-A, and conglutinin caused viral precipitation through formation of massive viral aggregates, whereas MBL formed aggregates of smaller size that did not precipitate. All of the collectins enhanced IAV binding to neutrophils; however, in the case of MBL, this effect was modest compared with the binding enhancement induced by SP-D or conglutinin. These studies clarify the structural requirements for viral inhibition by SP-D and reveal significant differences in the mechanisms of anti-IAV activity among the collectins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435570     DOI: 10.1152/ajplung.1997.273.6.L1156

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  73 in total

1.  Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.

Authors:  Kevan L Hartshorn; Mitchell R White; Erika C Crouch
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity.

Authors:  K L Hartshorn; M R White; D R Voelker; J Coburn; K Zaner; E C Crouch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.

Authors:  Jeremy C Jones; Erik W Settles; Curtis R Brandt; Stacey Schultz-Cherry
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

4.  Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Authors:  Michelle D Tate; Danielle L Pickett; Nico van Rooijen; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.

Authors:  Jerome P Jayasekera; E Ashley Moseman; Michael C Carroll
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 6.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

7.  Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change.

Authors:  Feifei Shang; Michael J Rynkiewicz; Francis X McCormack; Huixing Wu; Tanya M Cafarella; James F Head; Barbara A Seaton
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

8.  Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.

Authors:  M J Allen; R Harbeck; B Smith; D R Voelker; R J Mason
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

9.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

10.  Viral aggregating and opsonizing activity in collectin trimers.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Grith Sorensen; Uffe Holmskov; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.